Daewoong Pharmaceutical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Seongsoo Park
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 2.2yrs |
Recent management updates
Recent updates
CEO
Seongsoo Park (47 yo)
less than a year
Tenure
Mr. Seongsoo Park serves as Director of AEON Biopharma, Inc. since April 2024. Mr. Park has served as the Chief Executive Officer of Daewoong since April 2024. From April 2015 to March 2024, Mr. Park serve...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 1.2yrs | no data | no data | |
CEO & Executive Director | 3.2yrs | no data | 0.0046% ₩ 59.5m | |
Independent Outside Director | 6.3yrs | no data | no data | |
Independent Outside Director | 2.2yrs | no data | no data | |
Independent Outside Director | 1.2yrs | no data | no data |
2.2yrs
Average Tenure
Experienced Board: A069620's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.